nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS3—type 2 diabetes mellitus	0.324	0.509	CbGaD
L-Arginine—NOS2—type 2 diabetes mellitus	0.313	0.491	CbGaD
L-Arginine—NOS3—femoral artery—type 2 diabetes mellitus	0.0196	0.183	CbGeAlD
L-Arginine—NOS3—middle cerebral artery—type 2 diabetes mellitus	0.0135	0.126	CbGeAlD
L-Arginine—NOS3—arteriole—type 2 diabetes mellitus	0.0119	0.111	CbGeAlD
L-Arginine—NOS3—tunica intima—type 2 diabetes mellitus	0.00842	0.0788	CbGeAlD
L-Arginine—NOS3—penis—type 2 diabetes mellitus	0.00623	0.0583	CbGeAlD
L-Arginine—NOS3—hindlimb—type 2 diabetes mellitus	0.0047	0.044	CbGeAlD
L-Arginine—NOS3—artery—type 2 diabetes mellitus	0.00288	0.027	CbGeAlD
L-Arginine—ASL—kidney—type 2 diabetes mellitus	0.0025	0.0234	CbGeAlD
L-Arginine—NOS3—endothelium—type 2 diabetes mellitus	0.00244	0.0228	CbGeAlD
L-Arginine—AZIN2—adipose tissue—type 2 diabetes mellitus	0.00243	0.0227	CbGeAlD
L-Arginine—Skin exfoliation—Linagliptin—type 2 diabetes mellitus	0.00239	0.026	CcSEcCtD
L-Arginine—ASL—adipose tissue—type 2 diabetes mellitus	0.00226	0.0211	CbGeAlD
L-Arginine—Numbness—Bromocriptine—type 2 diabetes mellitus	0.00171	0.0186	CcSEcCtD
L-Arginine—ARG2—retina—type 2 diabetes mellitus	0.0017	0.0159	CbGeAlD
L-Arginine—SLC7A1—cardiovascular system—type 2 diabetes mellitus	0.00168	0.0157	CbGeAlD
L-Arginine—Sensory loss—Bromocriptine—type 2 diabetes mellitus	0.00163	0.0178	CcSEcCtD
L-Arginine—ARG2—nephron tubule—type 2 diabetes mellitus	0.0016	0.0149	CbGeAlD
L-Arginine—L-Methionine—BHMT—type 2 diabetes mellitus	0.00159	0.192	CrCbGaD
L-Arginine—ASL—liver—type 2 diabetes mellitus	0.00158	0.0148	CbGeAlD
L-Arginine—SLC7A1—adipose tissue—type 2 diabetes mellitus	0.00148	0.0138	CbGeAlD
L-Arginine—ARG2—kidney—type 2 diabetes mellitus	0.0014	0.0131	CbGeAlD
L-Arginine—Numbness—Gliclazide—type 2 diabetes mellitus	0.0014	0.0152	CcSEcCtD
L-Arginine—ASS1—islet of Langerhans—type 2 diabetes mellitus	0.00139	0.013	CbGeAlD
L-Arginine—ARG2—cortex of kidney—type 2 diabetes mellitus	0.00137	0.0128	CbGeAlD
L-Arginine—Sensory loss—Gliclazide—type 2 diabetes mellitus	0.00134	0.0146	CcSEcCtD
L-Arginine—L-Serine—SRR—type 2 diabetes mellitus	0.00127	0.154	CrCbGaD
L-Arginine—ARG2—adipose tissue—type 2 diabetes mellitus	0.00126	0.0118	CbGeAlD
L-Arginine—Sweating—Nateglinide—type 2 diabetes mellitus	0.00126	0.0137	CcSEcCtD
L-Arginine—L-Methionine—MAT1A—type 2 diabetes mellitus	0.0012	0.146	CrCbGaD
L-Arginine—ASS1—nephron tubule—type 2 diabetes mellitus	0.00112	0.0105	CbGeAlD
L-Arginine—Numbness—Irbesartan—type 2 diabetes mellitus	0.00111	0.012	CcSEcCtD
L-Arginine—Sensory loss—Irbesartan—type 2 diabetes mellitus	0.00106	0.0115	CcSEcCtD
L-Arginine—Lethargy—Bromocriptine—type 2 diabetes mellitus	0.00105	0.0114	CcSEcCtD
L-Arginine—L-Cysteine—CDO1—type 2 diabetes mellitus	0.00101	0.123	CrCbGaD
L-Arginine—ASS1—cardiovascular system—type 2 diabetes mellitus	0.00101	0.0094	CbGeAlD
L-Arginine—NOS3—cardiovascular system—type 2 diabetes mellitus	0.001	0.00937	CbGeAlD
L-Arginine—ASS1—kidney—type 2 diabetes mellitus	0.000983	0.0092	CbGeAlD
L-Arginine—NOS3—kidney—type 2 diabetes mellitus	0.00098	0.00917	CbGeAlD
L-Arginine—ASS1—pancreas—type 2 diabetes mellitus	0.000977	0.00914	CbGeAlD
L-Arginine—ASS1—cortex of kidney—type 2 diabetes mellitus	0.000958	0.00896	CbGeAlD
L-Arginine—Sweating—Glipizide—type 2 diabetes mellitus	0.000901	0.0098	CcSEcCtD
L-Arginine—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.000894	0.00973	CcSEcCtD
L-Arginine—ASS1—adipose tissue—type 2 diabetes mellitus	0.000886	0.00829	CbGeAlD
L-Arginine—Swelling—Valsartan—type 2 diabetes mellitus	0.000878	0.00955	CcSEcCtD
L-Arginine—Sweating—Pioglitazone—type 2 diabetes mellitus	0.000863	0.00939	CcSEcCtD
L-Arginine—Anorexia—Chlorpropamide—type 2 diabetes mellitus	0.000861	0.00937	CcSEcCtD
L-Arginine—Haematuria—Pioglitazone—type 2 diabetes mellitus	0.000859	0.00934	CcSEcCtD
L-Arginine—Sweating—Glimepiride—type 2 diabetes mellitus	0.000841	0.00915	CcSEcCtD
L-Arginine—Hypoaesthesia—Glipizide—type 2 diabetes mellitus	0.00084	0.00913	CcSEcCtD
L-Arginine—Skin exfoliation—Losartan—type 2 diabetes mellitus	0.000824	0.00896	CcSEcCtD
L-Arginine—L-Serine—CBS—type 2 diabetes mellitus	0.000819	0.0994	CrCbGaD
L-Arginine—Hyperhidrosis—Nateglinide—type 2 diabetes mellitus	0.000809	0.0088	CcSEcCtD
L-Arginine—Hypoaesthesia—Pioglitazone—type 2 diabetes mellitus	0.000804	0.00875	CcSEcCtD
L-Arginine—SLC16A10—nephron tubule—type 2 diabetes mellitus	0.000799	0.00748	CbGeAlD
L-Arginine—Decreased appetite—Chlorpropamide—type 2 diabetes mellitus	0.000786	0.00855	CcSEcCtD
L-Arginine—Flushing—Glipizide—type 2 diabetes mellitus	0.000783	0.00852	CcSEcCtD
L-Arginine—Hypoaesthesia—Sitagliptin—type 2 diabetes mellitus	0.000781	0.0085	CcSEcCtD
L-Arginine—Swelling—Irbesartan—type 2 diabetes mellitus	0.000755	0.00821	CcSEcCtD
L-Arginine—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.000725	0.00788	CcSEcCtD
L-Arginine—Lethargy—Metformin—type 2 diabetes mellitus	0.00072	0.00783	CcSEcCtD
L-Arginine—SLC22A4—nephron tubule—type 2 diabetes mellitus	0.000712	0.00666	CbGeAlD
L-Arginine—Swelling—Losartan—type 2 diabetes mellitus	0.00071	0.00772	CcSEcCtD
L-Arginine—Hypoaesthesia—Bromocriptine—type 2 diabetes mellitus	0.000707	0.00769	CcSEcCtD
L-Arginine—Rash—Miglitol—type 2 diabetes mellitus	0.000697	0.00758	CcSEcCtD
L-Arginine—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000696	0.00757	CcSEcCtD
L-Arginine—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000685	0.00745	CcSEcCtD
L-Arginine—SLC16A10—cortex of kidney—type 2 diabetes mellitus	0.000684	0.0064	CbGeAlD
L-Arginine—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000659	0.00717	CcSEcCtD
L-Arginine—Nausea—Miglitol—type 2 diabetes mellitus	0.000656	0.00714	CcSEcCtD
L-Arginine—L-Cysteine—CBS—type 2 diabetes mellitus	0.000653	0.0792	CrCbGaD
L-Arginine—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00064	0.00696	CcSEcCtD
L-Arginine—SLC16A10—adipose tissue—type 2 diabetes mellitus	0.000633	0.00592	CbGeAlD
L-Arginine—Rash—Tolbutamide—type 2 diabetes mellitus	0.000626	0.00681	CcSEcCtD
L-Arginine—SLC22A4—kidney—type 2 diabetes mellitus	0.000626	0.00585	CbGeAlD
L-Arginine—Sweating—Gliclazide—type 2 diabetes mellitus	0.000623	0.00677	CcSEcCtD
L-Arginine—Headache—Tolbutamide—type 2 diabetes mellitus	0.000622	0.00677	CcSEcCtD
L-Arginine—ASS1—liver—type 2 diabetes mellitus	0.000622	0.00581	CbGeAlD
L-Arginine—NOS3—liver—type 2 diabetes mellitus	0.00062	0.0058	CbGeAlD
L-Arginine—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000617	0.00671	CcSEcCtD
L-Arginine—SLC22A4—cortex of kidney—type 2 diabetes mellitus	0.000609	0.0057	CbGeAlD
L-Arginine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00059	0.00642	CcSEcCtD
L-Arginine—Hypoaesthesia—Gliclazide—type 2 diabetes mellitus	0.00058	0.00631	CcSEcCtD
L-Arginine—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.00058	0.0063	CcSEcCtD
L-Arginine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000575	0.00625	CcSEcCtD
L-Arginine—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000574	0.00625	CcSEcCtD
L-Arginine—Anorexia—Glipizide—type 2 diabetes mellitus	0.000572	0.00622	CcSEcCtD
L-Arginine—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00057	0.0062	CcSEcCtD
L-Arginine—Rash—Tolazamide—type 2 diabetes mellitus	0.00057	0.0062	CcSEcCtD
L-Arginine—Headache—Tolazamide—type 2 diabetes mellitus	0.000566	0.00616	CcSEcCtD
L-Arginine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000566	0.00616	CcSEcCtD
L-Arginine—Rash—Linagliptin—type 2 diabetes mellitus	0.000564	0.00613	CcSEcCtD
L-Arginine—SLC22A4—adipose tissue—type 2 diabetes mellitus	0.000564	0.00527	CbGeAlD
L-Arginine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000563	0.00613	CcSEcCtD
L-Arginine—Headache—Linagliptin—type 2 diabetes mellitus	0.00056	0.00609	CcSEcCtD
L-Arginine—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00056	0.00609	CcSEcCtD
L-Arginine—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000558	0.00607	CcSEcCtD
L-Arginine—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000555	0.00604	CcSEcCtD
L-Arginine—Vomiting—Acarbose—type 2 diabetes mellitus	0.000552	0.00601	CcSEcCtD
L-Arginine—Rash—Acarbose—type 2 diabetes mellitus	0.000547	0.00596	CcSEcCtD
L-Arginine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000547	0.00595	CcSEcCtD
L-Arginine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000546	0.00594	CcSEcCtD
L-Arginine—Flushing—Gliclazide—type 2 diabetes mellitus	0.000541	0.00589	CcSEcCtD
L-Arginine—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000541	0.00588	CcSEcCtD
L-Arginine—Nausea—Tolazamide—type 2 diabetes mellitus	0.000537	0.00584	CcSEcCtD
L-Arginine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000537	0.00584	CcSEcCtD
L-Arginine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000534	0.00581	CcSEcCtD
L-Arginine—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000533	0.0058	CcSEcCtD
L-Arginine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000532	0.00579	CcSEcCtD
L-Arginine—Rash—Nateglinide—type 2 diabetes mellitus	0.000528	0.00574	CcSEcCtD
L-Arginine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000527	0.00574	CcSEcCtD
L-Arginine—L-Methionine—MTR—type 2 diabetes mellitus	0.000523	0.0635	CrCbGaD
L-Arginine—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000521	0.00567	CcSEcCtD
L-Arginine—Nausea—Acarbose—type 2 diabetes mellitus	0.000516	0.00561	CcSEcCtD
L-Arginine—SLC22A5—retina—type 2 diabetes mellitus	0.0005	0.00468	CbGeAlD
L-Arginine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000497	0.00541	CcSEcCtD
L-Arginine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000493	0.00536	CcSEcCtD
L-Arginine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000486	0.00529	CcSEcCtD
L-Arginine—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.000486	0.00528	CcSEcCtD
L-Arginine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000485	0.00527	CcSEcCtD
L-Arginine—L-Citrulline—NOS1—type 2 diabetes mellitus	0.000482	0.0585	CrCbGaD
L-Arginine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000481	0.00523	CcSEcCtD
L-Arginine—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.000471	0.00441	CbGeAlD
L-Arginine—Sweating—Losartan—type 2 diabetes mellitus	0.000463	0.00503	CcSEcCtD
L-Arginine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000461	0.00501	CcSEcCtD
L-Arginine—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000458	0.00498	CcSEcCtD
L-Arginine—Rash—Repaglinide—type 2 diabetes mellitus	0.000457	0.00497	CcSEcCtD
L-Arginine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000457	0.00497	CcSEcCtD
L-Arginine—Headache—Repaglinide—type 2 diabetes mellitus	0.000454	0.00494	CcSEcCtD
L-Arginine—Flushing—Metformin—type 2 diabetes mellitus	0.000453	0.00493	CcSEcCtD
L-Arginine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000446	0.00485	CcSEcCtD
L-Arginine—SLC16A10—liver—type 2 diabetes mellitus	0.000444	0.00415	CbGeAlD
L-Arginine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000442	0.00481	CcSEcCtD
L-Arginine—Anorexia—Glyburide—type 2 diabetes mellitus	0.00044	0.00478	CcSEcCtD
L-Arginine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000439	0.00477	CcSEcCtD
L-Arginine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000432	0.0047	CcSEcCtD
L-Arginine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000431	0.00469	CcSEcCtD
L-Arginine—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000431	0.00469	CcSEcCtD
L-Arginine—Nausea—Repaglinide—type 2 diabetes mellitus	0.00043	0.00468	CcSEcCtD
L-Arginine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000429	0.00467	CcSEcCtD
L-Arginine—Flushing—Irbesartan—type 2 diabetes mellitus	0.000427	0.00465	CcSEcCtD
L-Arginine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000423	0.0046	CcSEcCtD
L-Arginine—SLC22A5—kidney—type 2 diabetes mellitus	0.000414	0.00387	CbGeAlD
L-Arginine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000412	0.00448	CcSEcCtD
L-Arginine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000411	0.00447	CcSEcCtD
L-Arginine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000407	0.00443	CcSEcCtD
L-Arginine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000404	0.0044	CcSEcCtD
L-Arginine—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000403	0.00377	CbGeAlD
L-Arginine—Flushing—Losartan—type 2 diabetes mellitus	0.000402	0.00437	CcSEcCtD
L-Arginine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000401	0.00436	CcSEcCtD
L-Arginine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000401	0.00436	CcSEcCtD
L-Arginine—Sweating—Ramipril—type 2 diabetes mellitus	0.000397	0.00432	CcSEcCtD
L-Arginine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000381	0.00415	CcSEcCtD
L-Arginine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000381	0.00414	CcSEcCtD
L-Arginine—Rash—Glipizide—type 2 diabetes mellitus	0.000378	0.00411	CcSEcCtD
L-Arginine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000378	0.00411	CcSEcCtD
L-Arginine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000376	0.00409	CcSEcCtD
L-Arginine—Headache—Glipizide—type 2 diabetes mellitus	0.000376	0.00409	CcSEcCtD
L-Arginine—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.000373	0.00349	CbGeAlD
L-Arginine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000364	0.00396	CcSEcCtD
L-Arginine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000363	0.00395	CcSEcCtD
L-Arginine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00036	0.00391	CcSEcCtD
L-Arginine—Nausea—Glipizide—type 2 diabetes mellitus	0.000356	0.00387	CcSEcCtD
L-Arginine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000356	0.00387	CcSEcCtD
L-Arginine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000355	0.00386	CcSEcCtD
L-Arginine—Rash—Glimepiride—type 2 diabetes mellitus	0.000353	0.00384	CcSEcCtD
L-Arginine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000352	0.00383	CcSEcCtD
L-Arginine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000352	0.00383	CcSEcCtD
L-Arginine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000351	0.00382	CcSEcCtD
L-Arginine—Headache—Glimepiride—type 2 diabetes mellitus	0.000351	0.00381	CcSEcCtD
L-Arginine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000349	0.0038	CcSEcCtD
L-Arginine—Flushing—Ramipril—type 2 diabetes mellitus	0.000345	0.00375	CcSEcCtD
L-Arginine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00034	0.0037	CcSEcCtD
L-Arginine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000335	0.00365	CcSEcCtD
L-Arginine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000332	0.00362	CcSEcCtD
L-Arginine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000331	0.0036	CcSEcCtD
L-Arginine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000331	0.0036	CcSEcCtD
L-Arginine—Anorexia—Metformin—type 2 diabetes mellitus	0.00033	0.00359	CcSEcCtD
L-Arginine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000327	0.00356	CcSEcCtD
L-Arginine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000327	0.00356	CcSEcCtD
L-Arginine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000321	0.00349	CcSEcCtD
L-Arginine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000319	0.00347	CcSEcCtD
L-Arginine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000318	0.00346	CcSEcCtD
L-Arginine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000318	0.00346	CcSEcCtD
L-Arginine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000316	0.00344	CcSEcCtD
L-Arginine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000316	0.00344	CcSEcCtD
L-Arginine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000312	0.00339	CcSEcCtD
L-Arginine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000308	0.00335	CcSEcCtD
L-Arginine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000305	0.00332	CcSEcCtD
L-Arginine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000301	0.00328	CcSEcCtD
L-Arginine—Tachycardia—Losartan—type 2 diabetes mellitus	0.0003	0.00327	CcSEcCtD
L-Arginine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.0003	0.00326	CcSEcCtD
L-Arginine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000298	0.00324	CcSEcCtD
L-Arginine—Anorexia—Losartan—type 2 diabetes mellitus	0.000293	0.00319	CcSEcCtD
L-Arginine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000293	0.00319	CcSEcCtD
L-Arginine—Rash—Glyburide—type 2 diabetes mellitus	0.000291	0.00316	CcSEcCtD
L-Arginine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000291	0.00316	CcSEcCtD
L-Arginine—Headache—Glyburide—type 2 diabetes mellitus	0.000289	0.00314	CcSEcCtD
L-Arginine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000284	0.00309	CcSEcCtD
L-Arginine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00028	0.00305	CcSEcCtD
L-Arginine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000277	0.00301	CcSEcCtD
L-Arginine—Nausea—Glyburide—type 2 diabetes mellitus	0.000274	0.00298	CcSEcCtD
L-Arginine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000268	0.00291	CcSEcCtD
L-Arginine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000264	0.00287	CcSEcCtD
L-Arginine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000263	0.00287	CcSEcCtD
L-Arginine—L-Citrulline—NOS3—type 2 diabetes mellitus	0.000262	0.0318	CrCbGaD
L-Arginine—SLC22A5—liver—type 2 diabetes mellitus	0.000262	0.00245	CbGeAlD
L-Arginine—Rash—Gliclazide—type 2 diabetes mellitus	0.000261	0.00284	CcSEcCtD
L-Arginine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000261	0.00284	CcSEcCtD
L-Arginine—Headache—Gliclazide—type 2 diabetes mellitus	0.00026	0.00282	CcSEcCtD
L-Arginine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000258	0.0028	CcSEcCtD
L-Arginine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000255	0.00278	CcSEcCtD
L-Arginine—L-Citrulline—NOS2—type 2 diabetes mellitus	0.000253	0.0307	CrCbGaD
L-Arginine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000252	0.00274	CcSEcCtD
L-Arginine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000246	0.00268	CcSEcCtD
L-Arginine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000242	0.00263	CcSEcCtD
L-Arginine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000241	0.00262	CcSEcCtD
L-Arginine—Rash—Valsartan—type 2 diabetes mellitus	0.00024	0.00261	CcSEcCtD
L-Arginine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00024	0.00261	CcSEcCtD
L-Arginine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000239	0.0026	CcSEcCtD
L-Arginine—Headache—Valsartan—type 2 diabetes mellitus	0.000238	0.00259	CcSEcCtD
L-Arginine—Rash—Orlistat—type 2 diabetes mellitus	0.000237	0.00258	CcSEcCtD
L-Arginine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000237	0.00258	CcSEcCtD
L-Arginine—Headache—Orlistat—type 2 diabetes mellitus	0.000236	0.00256	CcSEcCtD
L-Arginine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000229	0.0025	CcSEcCtD
L-Arginine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000227	0.00247	CcSEcCtD
L-Arginine—Nausea—Valsartan—type 2 diabetes mellitus	0.000226	0.00246	CcSEcCtD
L-Arginine—Nausea—Orlistat—type 2 diabetes mellitus	0.000223	0.00243	CcSEcCtD
L-Arginine—Vomiting—Metformin—type 2 diabetes mellitus	0.00022	0.0024	CcSEcCtD
L-Arginine—Rash—Metformin—type 2 diabetes mellitus	0.000219	0.00238	CcSEcCtD
L-Arginine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000218	0.00238	CcSEcCtD
L-Arginine—Headache—Metformin—type 2 diabetes mellitus	0.000217	0.00236	CcSEcCtD
L-Arginine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000208	0.00226	CcSEcCtD
L-Arginine—Rash—Irbesartan—type 2 diabetes mellitus	0.000206	0.00224	CcSEcCtD
L-Arginine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000206	0.00224	CcSEcCtD
L-Arginine—Nausea—Metformin—type 2 diabetes mellitus	0.000206	0.00224	CcSEcCtD
L-Arginine—Headache—Irbesartan—type 2 diabetes mellitus	0.000205	0.00223	CcSEcCtD
L-Arginine—Vomiting—Losartan—type 2 diabetes mellitus	0.000196	0.00213	CcSEcCtD
L-Arginine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000195	0.00212	CcSEcCtD
L-Arginine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000194	0.00211	CcSEcCtD
L-Arginine—Rash—Losartan—type 2 diabetes mellitus	0.000194	0.00211	CcSEcCtD
L-Arginine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000194	0.00211	CcSEcCtD
L-Arginine—Headache—Losartan—type 2 diabetes mellitus	0.000193	0.0021	CcSEcCtD
L-Arginine—Nausea—Losartan—type 2 diabetes mellitus	0.000183	0.00199	CcSEcCtD
L-Arginine—L-Methionine—MTHFR—type 2 diabetes mellitus	0.000179	0.0217	CrCbGaD
L-Arginine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000168	0.00183	CcSEcCtD
L-Arginine—Rash—Ramipril—type 2 diabetes mellitus	0.000166	0.00181	CcSEcCtD
L-Arginine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000166	0.00181	CcSEcCtD
L-Arginine—Headache—Ramipril—type 2 diabetes mellitus	0.000165	0.0018	CcSEcCtD
L-Arginine—Nausea—Ramipril—type 2 diabetes mellitus	0.000157	0.00171	CcSEcCtD
L-Arginine—NOS3—Hemostasis—MMP1—type 2 diabetes mellitus	2.64e-05	0.00017	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HK1—type 2 diabetes mellitus	2.64e-05	0.00017	CbGpPWpGaD
L-Arginine—NOS2—Disease—CALCA—type 2 diabetes mellitus	2.62e-05	0.000168	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.62e-05	0.000168	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GIP—type 2 diabetes mellitus	2.6e-05	0.000167	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SERPINE1—type 2 diabetes mellitus	2.59e-05	0.000166	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—ALB—type 2 diabetes mellitus	2.58e-05	0.000166	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.58e-05	0.000166	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.58e-05	0.000166	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—NOS3—type 2 diabetes mellitus	2.58e-05	0.000166	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—IL6—type 2 diabetes mellitus	2.57e-05	0.000165	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—CALM1—type 2 diabetes mellitus	2.57e-05	0.000165	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—MTHFR—type 2 diabetes mellitus	2.56e-05	0.000165	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HSD3B2—type 2 diabetes mellitus	2.55e-05	0.000164	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GCKR—type 2 diabetes mellitus	2.55e-05	0.000164	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—KCNJ11—type 2 diabetes mellitus	2.55e-05	0.000164	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—LPA—type 2 diabetes mellitus	2.55e-05	0.000164	CbGpPWpGaD
L-Arginine—NOS3—Disease—SLC2A2—type 2 diabetes mellitus	2.54e-05	0.000163	CbGpPWpGaD
L-Arginine—NOS2—Disease—SLC2A1—type 2 diabetes mellitus	2.53e-05	0.000163	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—APOA1—type 2 diabetes mellitus	2.53e-05	0.000163	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PPARA—type 2 diabetes mellitus	2.51e-05	0.000161	CbGpPWpGaD
L-Arginine—NOS2—Disease—NOS1—type 2 diabetes mellitus	2.49e-05	0.00016	CbGpPWpGaD
L-Arginine—NOS3—Disease—MTR—type 2 diabetes mellitus	2.49e-05	0.00016	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.47e-05	0.000159	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NOS3—type 2 diabetes mellitus	2.47e-05	0.000159	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3R1—type 2 diabetes mellitus	2.47e-05	0.000159	CbGpPWpGaD
L-Arginine—NOS2—Disease—TCF7L2—type 2 diabetes mellitus	2.47e-05	0.000159	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—type 2 diabetes mellitus	2.46e-05	0.000158	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.46e-05	0.000158	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ALDOB—type 2 diabetes mellitus	2.45e-05	0.000157	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.45e-05	0.000157	CbGpPWpGaD
L-Arginine—NOS3—Disease—NAMPT—type 2 diabetes mellitus	2.44e-05	0.000157	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.44e-05	0.000157	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AGT—type 2 diabetes mellitus	2.43e-05	0.000156	CbGpPWpGaD
L-Arginine—NOS2—Disease—SLC2A4—type 2 diabetes mellitus	2.43e-05	0.000156	CbGpPWpGaD
L-Arginine—NOS3—Disease—GCK—type 2 diabetes mellitus	2.42e-05	0.000156	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.42e-05	0.000155	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.41e-05	0.000155	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PRKCB—type 2 diabetes mellitus	2.41e-05	0.000155	CbGpPWpGaD
L-Arginine—NOS3—Disease—IAPP—type 2 diabetes mellitus	2.41e-05	0.000155	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CALM1—type 2 diabetes mellitus	2.39e-05	0.000154	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NOS2—type 2 diabetes mellitus	2.38e-05	0.000153	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—APOE—type 2 diabetes mellitus	2.38e-05	0.000153	CbGpPWpGaD
L-Arginine—NOS3—Disease—SLC9A1—type 2 diabetes mellitus	2.36e-05	0.000152	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.36e-05	0.000152	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—APOA1—type 2 diabetes mellitus	2.36e-05	0.000151	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—type 2 diabetes mellitus	2.36e-05	0.000151	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.33e-05	0.00015	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.3e-05	0.000148	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GLP1R—type 2 diabetes mellitus	2.28e-05	0.000146	CbGpPWpGaD
L-Arginine—NOS3—Disease—HMGA1—type 2 diabetes mellitus	2.22e-05	0.000142	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ADRB3—type 2 diabetes mellitus	2.21e-05	0.000142	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—AKT1—type 2 diabetes mellitus	2.19e-05	0.000141	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.18e-05	0.00014	CbGpPWpGaD
L-Arginine—NOS3—Disease—PSMD6—type 2 diabetes mellitus	2.17e-05	0.00014	CbGpPWpGaD
L-Arginine—NOS3—Disease—SNAP25—type 2 diabetes mellitus	2.17e-05	0.00014	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CRHR1—type 2 diabetes mellitus	2.13e-05	0.000137	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC2A2—type 2 diabetes mellitus	2.12e-05	0.000137	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IGF1—type 2 diabetes mellitus	2.11e-05	0.000136	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT2—type 2 diabetes mellitus	2.11e-05	0.000136	CbGpPWpGaD
L-Arginine—NOS2—Disease—TGFBR2—type 2 diabetes mellitus	2.11e-05	0.000136	CbGpPWpGaD
L-Arginine—NOS3—Disease—CYBA—type 2 diabetes mellitus	2.1e-05	0.000135	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—MTR—type 2 diabetes mellitus	2.08e-05	0.000134	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CPT1A—type 2 diabetes mellitus	2.08e-05	0.000134	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PPARG—type 2 diabetes mellitus	2.08e-05	0.000133	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN2B—type 2 diabetes mellitus	2.04e-05	0.000131	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NAMPT—type 2 diabetes mellitus	2.04e-05	0.000131	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—INS—type 2 diabetes mellitus	2.04e-05	0.000131	CbGpPWpGaD
L-Arginine—NOS3—Disease—CALCA—type 2 diabetes mellitus	2.03e-05	0.000131	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GCK—type 2 diabetes mellitus	2.03e-05	0.00013	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HBA1—type 2 diabetes mellitus	2.03e-05	0.00013	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—LIPC—type 2 diabetes mellitus	2.03e-05	0.00013	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP11A1—type 2 diabetes mellitus	2.02e-05	0.00013	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SERPINE1—type 2 diabetes mellitus	2.01e-05	0.000129	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—ALB—type 2 diabetes mellitus	2e-05	0.000129	CbGpPWpGaD
L-Arginine—NOS2—Disease—APOB—type 2 diabetes mellitus	1.99e-05	0.000128	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC9A1—type 2 diabetes mellitus	1.98e-05	0.000127	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.97e-05	0.000127	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.97e-05	0.000126	CbGpPWpGaD
L-Arginine—NOS3—Disease—SLC2A1—type 2 diabetes mellitus	1.96e-05	0.000126	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CETP—type 2 diabetes mellitus	1.96e-05	0.000126	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.95e-05	0.000125	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.95e-05	0.000125	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.95e-05	0.000125	CbGpPWpGaD
L-Arginine—NOS3—Disease—NOS1—type 2 diabetes mellitus	1.94e-05	0.000124	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3R1—type 2 diabetes mellitus	1.92e-05	0.000123	CbGpPWpGaD
L-Arginine—NOS3—Disease—TCF7L2—type 2 diabetes mellitus	1.92e-05	0.000123	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.92e-05	0.000123	CbGpPWpGaD
L-Arginine—NOS2—Disease—LPL—type 2 diabetes mellitus	1.9e-05	0.000122	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.9e-05	0.000122	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.9e-05	0.000122	CbGpPWpGaD
L-Arginine—NOS3—Disease—SLC2A4—type 2 diabetes mellitus	1.88e-05	0.000121	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.87e-05	0.00012	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ALB—type 2 diabetes mellitus	1.87e-05	0.00012	CbGpPWpGaD
L-Arginine—NOS2—Disease—ADCY5—type 2 diabetes mellitus	1.86e-05	0.00012	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.85e-05	0.000119	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SRC—type 2 diabetes mellitus	1.83e-05	0.000117	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PSMD6—type 2 diabetes mellitus	1.82e-05	0.000117	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SNAP25—type 2 diabetes mellitus	1.82e-05	0.000117	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SREBF1—type 2 diabetes mellitus	1.82e-05	0.000117	CbGpPWpGaD
L-Arginine—NOS2—Disease—PPP2CA—type 2 diabetes mellitus	1.79e-05	0.000115	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CTGF—type 2 diabetes mellitus	1.79e-05	0.000115	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.79e-05	0.000115	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—NOS3—type 2 diabetes mellitus	1.79e-05	0.000115	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—type 2 diabetes mellitus	1.78e-05	0.000114	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HMGCR—type 2 diabetes mellitus	1.77e-05	0.000114	CbGpPWpGaD
L-Arginine—NOS2—Disease—CCR5—type 2 diabetes mellitus	1.75e-05	0.000113	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ADRA2A—type 2 diabetes mellitus	1.73e-05	0.000111	CbGpPWpGaD
L-Arginine—NOS2—Disease—MTHFR—type 2 diabetes mellitus	1.71e-05	0.00011	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.7e-05	0.000109	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.69e-05	0.000108	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—INSR—type 2 diabetes mellitus	1.68e-05	0.000108	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP2E1—type 2 diabetes mellitus	1.66e-05	0.000107	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.65e-05	0.000106	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC2A1—type 2 diabetes mellitus	1.65e-05	0.000106	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP1A2—type 2 diabetes mellitus	1.65e-05	0.000106	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFBR2—type 2 diabetes mellitus	1.64e-05	0.000105	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.64e-05	0.000105	CbGpPWpGaD
L-Arginine—NOS2—Disease—HIF1A—type 2 diabetes mellitus	1.63e-05	0.000105	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—type 2 diabetes mellitus	1.63e-05	0.000105	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TGFB1—type 2 diabetes mellitus	1.63e-05	0.000105	CbGpPWpGaD
L-Arginine—NOS2—Disease—IRS2—type 2 diabetes mellitus	1.63e-05	0.000105	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP3A4—type 2 diabetes mellitus	1.6e-05	0.000103	CbGpPWpGaD
L-Arginine—NOS2—Disease—CALM1—type 2 diabetes mellitus	1.6e-05	0.000103	CbGpPWpGaD
L-Arginine—NOS2—Disease—APOE—type 2 diabetes mellitus	1.6e-05	0.000103	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN2B—type 2 diabetes mellitus	1.59e-05	0.000102	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GCG—type 2 diabetes mellitus	1.58e-05	0.000101	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC2A4—type 2 diabetes mellitus	1.58e-05	0.000101	CbGpPWpGaD
L-Arginine—NOS2—Disease—APOA1—type 2 diabetes mellitus	1.58e-05	0.000101	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.57e-05	0.000101	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—type 2 diabetes mellitus	1.56e-05	0.0001	CbGpPWpGaD
L-Arginine—NOS3—Disease—APOB—type 2 diabetes mellitus	1.55e-05	9.95e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.52e-05	9.77e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.52e-05	9.77e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.48e-05	9.51e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—LPL—type 2 diabetes mellitus	1.48e-05	9.5e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.47e-05	9.47e-05	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.46e-05	9.4e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.45e-05	9.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—ADCY5—type 2 diabetes mellitus	1.45e-05	9.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.44e-05	9.27e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.44e-05	9.27e-05	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—type 2 diabetes mellitus	1.43e-05	9.18e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.42e-05	9.15e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—IRS1—type 2 diabetes mellitus	1.42e-05	9.15e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SRC—type 2 diabetes mellitus	1.42e-05	9.11e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PPP2CA—type 2 diabetes mellitus	1.39e-05	8.91e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—type 2 diabetes mellitus	1.38e-05	8.87e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—INS—type 2 diabetes mellitus	1.36e-05	8.76e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CCR5—type 2 diabetes mellitus	1.36e-05	8.75e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GNB3—type 2 diabetes mellitus	1.36e-05	8.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.36e-05	8.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HMOX1—type 2 diabetes mellitus	1.35e-05	8.7e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.34e-05	8.62e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CAT—type 2 diabetes mellitus	1.34e-05	8.58e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MTHFR—type 2 diabetes mellitus	1.33e-05	8.55e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GCG—type 2 diabetes mellitus	1.32e-05	8.47e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.32e-05	8.47e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT2—type 2 diabetes mellitus	1.32e-05	8.47e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.3e-05	8.34e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—APOB—type 2 diabetes mellitus	1.3e-05	8.33e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.29e-05	8.31e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HIF1A—type 2 diabetes mellitus	1.27e-05	8.15e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TGFB1—type 2 diabetes mellitus	1.27e-05	8.15e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—IRS2—type 2 diabetes mellitus	1.27e-05	8.13e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTM1—type 2 diabetes mellitus	1.26e-05	8.1e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—SERPINE1—type 2 diabetes mellitus	1.25e-05	8.04e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CALM1—type 2 diabetes mellitus	1.24e-05	7.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—APOE—type 2 diabetes mellitus	1.24e-05	7.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—LPL—type 2 diabetes mellitus	1.24e-05	7.95e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—APOA1—type 2 diabetes mellitus	1.22e-05	7.87e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ADCY5—type 2 diabetes mellitus	1.21e-05	7.79e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GPX1—type 2 diabetes mellitus	1.21e-05	7.76e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—NOS3—type 2 diabetes mellitus	1.2e-05	7.68e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3R1—type 2 diabetes mellitus	1.2e-05	7.68e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—type 2 diabetes mellitus	1.18e-05	7.61e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CD36—type 2 diabetes mellitus	1.18e-05	7.56e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPP2CA—type 2 diabetes mellitus	1.16e-05	7.46e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NOS2—type 2 diabetes mellitus	1.15e-05	7.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.15e-05	7.37e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.14e-05	7.3e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—type 2 diabetes mellitus	1.14e-05	7.29e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AVP—type 2 diabetes mellitus	1.12e-05	7.21e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.12e-05	7.21e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.12e-05	7.17e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—MTHFR—type 2 diabetes mellitus	1.11e-05	7.16e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.11e-05	7.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—IRS1—type 2 diabetes mellitus	1.11e-05	7.1e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPARA—type 2 diabetes mellitus	1.09e-05	7.02e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—type 2 diabetes mellitus	1.09e-05	7.02e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APOB—type 2 diabetes mellitus	1.08e-05	6.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.08e-05	6.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.07e-05	6.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AGT—type 2 diabetes mellitus	1.06e-05	6.8e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—INS—type 2 diabetes mellitus	1.06e-05	6.8e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CALM1—type 2 diabetes mellitus	1.04e-05	6.69e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—APOE—type 2 diabetes mellitus	1.04e-05	6.67e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—LPL—type 2 diabetes mellitus	1.04e-05	6.65e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—APOA1—type 2 diabetes mellitus	1.03e-05	6.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT2—type 2 diabetes mellitus	1.02e-05	6.57e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.01e-05	6.51e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—SERPINE1—type 2 diabetes mellitus	9.72e-06	6.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.71e-06	6.24e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.54e-06	6.13e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—C3—type 2 diabetes mellitus	9.32e-06	5.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3R1—type 2 diabetes mellitus	9.28e-06	5.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPARG—type 2 diabetes mellitus	9.04e-06	5.81e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.89e-06	5.71e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.87e-06	5.7e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—INS—type 2 diabetes mellitus	8.86e-06	5.69e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AGT—type 2 diabetes mellitus	8.85e-06	5.69e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—SRC—type 2 diabetes mellitus	8.84e-06	5.68e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—type 2 diabetes mellitus	8.81e-06	5.66e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.71e-06	5.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—LEP—type 2 diabetes mellitus	8.68e-06	5.57e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APOE—type 2 diabetes mellitus	8.68e-06	5.57e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.58e-06	5.51e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—type 2 diabetes mellitus	8.49e-06	5.45e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—type 2 diabetes mellitus	8.21e-06	5.27e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.18e-06	5.26e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ALB—type 2 diabetes mellitus	8.13e-06	5.22e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—TGFB1—type 2 diabetes mellitus	7.9e-06	5.08e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3R1—type 2 diabetes mellitus	7.77e-06	4.99e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—type 2 diabetes mellitus	7.75e-06	4.98e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.74e-06	4.97e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—INS—type 2 diabetes mellitus	7.41e-06	4.76e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.29e-06	4.69e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.17e-06	4.61e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.16e-06	4.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—type 2 diabetes mellitus	7.11e-06	4.57e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—SRC—type 2 diabetes mellitus	6.87e-06	4.41e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.81e-06	4.37e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.5e-06	4.18e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFB1—type 2 diabetes mellitus	6.14e-06	3.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RELA—type 2 diabetes mellitus	6.12e-06	3.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—type 2 diabetes mellitus	6.02e-06	3.87e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6—type 2 diabetes mellitus	5.96e-06	3.83e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.52e-06	3.55e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—type 2 diabetes mellitus	5.49e-06	3.53e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.21e-06	3.35e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.16e-06	3.31e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SRC—type 2 diabetes mellitus	4.81e-06	3.09e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.68e-06	3.01e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6—type 2 diabetes mellitus	4.62e-06	2.97e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.3e-06	2.76e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—type 2 diabetes mellitus	4.27e-06	2.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.21e-06	2.71e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—type 2 diabetes mellitus	3.57e-06	2.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6—type 2 diabetes mellitus	3.24e-06	2.08e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.99e-06	1.92e-05	CbGpPWpGaD
